Risk Factors for Inadequate Bowel Preparation Before Colonoscopy
Identification of Risk Factors for Inadequate Bowel Preparation Before Colonoscopy and Construction of a Predictive Model: a Nationwide Multicenter Prospective Study
1 other identifier
observational
10,000
1 country
1
Brief Summary
The primary objectives of this study are twofold: Firstly, to investigate the current status of bowel preparation protocols and their quality across hospitals at various levels in China, particularly following the release of the updated 2023 bowel preparation guidelines. This aims to standardize and optimize bowel preparation protocols nationwide. Secondly, to identify and analyze risk factors contributing to suboptimal bowel preparation quality in patients undergoing colonoscopy. The study will examine the correlation between these factors and bowel preparation scores, establish a risk prediction model for preparation failure, and provide a theoretical foundation for developing personalized bowel preparation regimens tailored to individual patient characteristics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 21, 2025
CompletedFirst Submitted
Initial submission to the registry
March 13, 2025
CompletedFirst Posted
Study publicly available on registry
March 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedMarch 18, 2025
March 1, 2025
12 months
March 13, 2025
March 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
adequate bowel preparation rate
The adequate bowel preparation rate can be assessed immediately upon completion of colonoscopy
Secondary Outcomes (1)
adenoma detection rate
1 year
Study Arms (1)
outpatients and inpatients scheduled for colonoscopy or polypectomy
The target population includes outpatients and inpatients scheduled for colonoscopy or polypectomy in the gastroenterology departments of participating centers between February 2025 and December 2026. Data from these individuals will be collected to assess factors influencing bowel preparation quality.
Interventions
Observed parameters include BMI, history of abdominal surgery, history of diabetes, history of diarrhea and constipation, stool characteristics, and specific bowel preparation protocols.
Eligibility Criteria
The target population includes outpatients and inpatients scheduled for colonoscopy or polypectomy in the gastroenterology departments of participating centers between February 2025 and February 2026.
You may qualify if:
- Patients aged \>18 years, regardless of gender, scheduled for colonoscopy
- Written informed consent has been obtained
You may not qualify if:
- History of acute myocardial infarction (within 6 months), severe cardiac/hepatic/renal insufficiency, or psychiatric disorders
- Current use of anticoagulants (e.g., aspirin, warfarin) or presence of coagulation disorders
- Pregnancy or lactation;
- History of inflammatory bowel disease or acute intestinal infection within the past 2 weeks;
- History of colorectal cancer, familial adenomatous polyposis (FAP), or Peutz-Jeghers syndrome;
- History of intestinal obstruction, perforation, stricture, or other conditions precluding completion of colonoscopy;
- Non-compliance with bowel preparation protocols (e.g., ingestion of \<80% of prescribed polyethylene glycol (PEG) electrolyte solution);
- Severe hearing impairment, cognitive dysfunction, or inability to cooperate with the study;
- Prior enrollment in this study with a repeat colonoscopy appointment;
- Current participation in other clinical trials or participation in any trial within the preceding 60 days;
- Refusal to provide written informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Changhai Hospital
Shanghai, Shanghai Municipality, 200433, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
March 13, 2025
First Posted
March 17, 2025
Study Start
February 21, 2025
Primary Completion
February 1, 2026
Study Completion
February 1, 2026
Last Updated
March 18, 2025
Record last verified: 2025-03